November 2020
Pfizer and BioNTech have reported that early trial data showed their vaccine to be more than 90 percent effective. What comes next for Pfizer and this vaccine, and what makes it different from dozens of other vaccines in the pipeline? Susan Ellenberg, PhD, comments.